GastroAGI Logo
OverviewBlogsAbout
Trending TopicsConference
Topics/Gallbladder and Pancreas/Pancreatic Plasticity in Development and Disease : Nat Rev Gastroenterol Hepatol | May 2026

Pancreatic Plasticity in Development and Disease : Nat Rev Gastroenterol Hepatol | May 2026

Clinical knowledge base curated and reviewed by GastroAGI TeamLast updated May 1, 2026

Quick Answer

Introduction The pancreas represents one of the most dynamic models of cellular plasticity in human biology, where developmental fate decisions, tissue maintenance and regenerative responses are orchestrated through tightly regulated transcriptional and microenvironmental interactions. Recent advances in single-cell sequencing, spatial transcriptomics and lineage-tracing technologies have transformed understanding of pancreatic ontogeny, uncovering previously unrecognized cellular heterogeneity and transient developmental states.


Introduction

The pancreas represents one of the most dynamic models of cellular plasticity in human biology, where developmental fate decisions, tissue maintenance and regenerative responses are orchestrated through tightly regulated transcriptional and microenvironmental interactions. Recent advances in single-cell sequencing, spatial transcriptomics and lineage-tracing technologies have transformed understanding of pancreatic ontogeny, uncovering previously unrecognized cellular heterogeneity and transient developmental states. Pancreatic Cancer and Diabetes have increasingly been linked to dysregulated cellular plasticity pathways that recapitulate embryonic developmental programs.

Problem Statement

Despite major progress in defining pancreatic cell lineages, the mechanisms governing lineage commitment, dedifferentiation and regeneration remain incompletely understood. The relationship between developmental plasticity and pathological reprogramming in adult pancreatic tissue is particularly important, as injury-induced or disease-associated plasticity may contribute both to tissue repair and malignant transformation. Understanding how pancreatic cell identity is established and destabilized is critical for advancing regenerative medicine, stem-cell–based therapies and novel therapeutic strategies for pancreatic diseases.

Summary

This review provides an integrated overview of pancreatic development and cellular plasticity across embryogenesis, tissue homeostasis and disease. Pancreatic organogenesis is presented as a highly coordinated process involving reciprocal signalling between pancreatic endoderm and surrounding mesenchymal, endothelial, neural and immune compartments. These interactions are integrated through complex gene regulatory networks governed by lineage-defining transcription factors that determine endocrine, acinar and ductal cell fates. Single-cell and spatial analyses have identified substantial cellular diversity within pancreatic tissue, including rare and transient intermediate states that appear critical for lineage specification and adaptive remodelling. The review highlights how developmental plasticity mechanisms persist into adulthood, where they may become reactivated during injury, inflammation and neoplastic transformation. In particular, adult pancreatic cells can undergo dedifferentiation and lineage conversion in response to stress, resembling embryonic transcriptional programs. Such plasticity may support tissue regeneration but can also facilitate tumorigenesis in pancreatic cancer. Importantly, insights derived from developmental biology have enabled the generation of pancreatic cell types from human pluripotent stem cells, advancing the field of regenerative therapeutics for diabetes and pancreatic disorders. Emerging in vitro systems that better reproduce pancreatic microenvironmental niches and multicellular interactions are now providing increasingly physiologic platforms for disease modelling and therapeutic development. Overall, the review positions cellular plasticity as a central biological principle linking pancreatic development, regeneration and disease pathogenesis, with major implications for future translational strategies.

Related Q&A

Ivonescimab Plus Gemcitabine–Cisplatin in Biliary Tract Cancer (BTC): Journal of Hepatology | July 2026

Introduction: Advanced biliary tract cancer (BTC) carries a poor prognosis, with limited improvements in survival despite the addition of immune checkpoint inhibitors to standard gemcitabine–cisplatin chemotherapy. This phase II trial evaluated ivonescimab, a novel PD-1/VEGF...

GLP-1 Receptor Agonists and Gallbladder Disease: UEG Journal | June 2026

Introduction: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have become a cornerstone in the management of type 2 diabetes because of their excellent glycemic, cardiovascular, and weight-loss benefits. However, concerns remain regarding their potential association with...

Remnant Duct Dilatation Rarely Signals IPMN Recurrence : Ann Surg | Jun 2026

Introduction: Patients undergoing pancreatoduodenectomy for non invasive intraductal papillary mucinous neoplasm (IPMN) require long-term surveillance because of the risk of disease recurrence in the pancreatic remnant. New pancreatic duct (PD) dilatation is commonly detected during...

Post-Pancreatectomy Chyle Leak: Annals of Surgery | June 2026

• This study evaluated 1,063 patients undergoing pancreatic surgery; 11% developed conventionally defined chyle leak. • Most clinically relevant cases were grade B, while no grade C leaks were reported. • A minimally invasive surgical...

Immediate Necrosectomy Accelerates Recovery in Walled-Off Necrosis : Gastroenterology | Jul 2026

Introduction: Endoscopic ultrasound (EUS)-guided drainage has become the preferred minimally invasive treatment for symptomatic necrotizing pancreatitis. However, the optimal timing of direct endoscopic necrosectomy (DEN) following drainage remains uncertain. While the conventional step-up approach reserves...

Fatty Pancreas: A Hidden Burden in T2DM : Diabetes Res Clin Pract | June 2026

Introduction: Fatty pancreas disease (FPD), also known as intrapancreatic fat deposition, has emerged as an important metabolic condition closely linked to obesity, insulin resistance, and type 2 diabetes mellitus (T2DM). Although ectopic fat accumulation in...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer